Minimally invasive hysterectomy is now considered the standard of care for the treatment of women with early-stage endometrial care.1,2 Compared with laparotomy, minimally invasive surgery (MIS) is associated with fewer complications, shorter hospital stays, and equivalent long-term survival.1,2 Minimally invasive hysterectomy can be performed either laparoscopically or as a robotically assisted procedure. Although large randomized trials are lacking, most studies have found that significant morbidity and mortality are similar for robotically assisted and laparoscopic hysterectomy for endometrial cancer.3 However, compared with laparoscopic hysterectomy, robotically assisted surgery is significantly more costly owing to capital expenditures for the robot, disposable instrumentation, and increased operating room time.4
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Wright JD, Khoury-Collado F, Melamed A. Harnessing Minimally Invasive Surgery to Improve Outcomes in Endometrial Cancer Surgery—The Robots Are Coming. JAMA Surg. 2019;154(6):539. doi:10.1001/jamasurg.2018.5841
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: